Both in Biotechnology
Sana Biotechnology vs Ginkgo Bioworks Holdings
Over the past year SANA returned −46.6% and DNA returned −15.9%; their daily moves had a correlation of 0.45.
SANA −46.6% DNA −15.9%Growth of $1, one year, split-adjusted
| Metric | SANA | DNA |
|---|---|---|
| Price | $2.44 | $10.76 |
| Market cap | $730.4M | $724.6M |
| Today | +1.67% | +9.24% |
| 1 month | −15.3% | −28.2% |
| 6 months | −30.1% | +10.8% |
| Year to date | −40.0% | +29.5% |
| 1 year | −50.7% | −17.2% |
| Revenue growth (YoY) | — | −48.5% |
| Gross margin | — | 91.5% |
| Net margin | — | −231.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.5× |
| Net cash | $160.5M | $302.2M |
| Dividend yield | — | — |
| Volatility (60d) | 72.6% | 128.2% |
| Short % of float | 22.2% | 18.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).